Table 2.

Factors associated with more expeditious suppression of plasma HIV RNA (<50 c/mL) among 676 HIV-infected patients initiating outpatient HIV medical care at the UAB 1917 and UW Harborview Clinics, January 2007 – October 2010.

Characteristic	Unadjusted HR (95% CI)	Adjusted HR (95% CI)
Age (per 10 years)	1.01 (0.92, 1.10)	0.93 (0.84, 1.02)
Sex × Race/ethnicity
Non-white Female	0.82 (0.58, 1.14)	0.76 (0.53, 1.09)
Non-white Male	1.24 (1.01, 1.53)*	1.10 (0.88, 1.37)
White Female	0.73 (0.44, 1.20)	0.91 (0.55, 1.52)
White Male	1.0	1.0
Health insurance
Private	1.28 (1.02, 1.61)*	1.37 (1.08, 1.73)**
Public	1.09 (0.85, 1.40)	1.17 (0.88, 1.56)
Uninsured	1.0	1.0
Baseline plasma HIV RNA (per 50,000 c/mL)	1.01 (1.00, 1.03)	0.97 (0.96, 0.99)**
Baseline CD4+ T lymphocyte count (cells/μL)
<200 cells/μL	2.97 (2.35, 3.76)**	3.74 (2.83, 4.95)**
200-350 cells/μL	2.73 (2.12, 3.50)**	2.95 (2.26, 3.86)**
>350 cells/μL	1.0	1.0
“No show” visits (per additional “no show”)	0.91 (0.83, 0.98)*	0.83 (0.76, 0.92)**

Hazard ratio: HR, 95% Confidence interval: 95% CI.

^*P<0.05,

^**P<0.01

Unadjusted and adjusted Cox proportional hazards models. Adjusted model controls for variables included in the table and study site.

“No show” = count of no show visits as a time-varying covariate